TrialJournal of clinical hypertension (Greenwich, Conn.)2020

Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.

Xuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.